For the quarter ending 2025-12-31, IBEX had -$7,234K decrease in cash & cash equivalents over the period. -$5,088K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net income | 12,217 | 12,042 | 36,864 |
| Depreciation and amortization | 4,750 | 4,378 | 17,232 |
| Noncash lease expense | 3,488 | 3,437 | 13,378 |
| Warrant contra revenue | - | - | 0 |
| Deferred income tax | -370 | -1,062 | -2,877 |
| Stock-based compensation expense | 1,114 | 2,550 | 5,432 |
| Allowance for expected credit losses | 173 | 52 | 514 |
| Impairment losses | - | - | 1,429 |
| Loss on lease terminations | - | - | 0 |
| Gain on sale of subsidiaries | - | - | 0 |
| Increase in accounts receivable | 14,591 | -1,015 | 19,262 |
| Increase in prepaid expenses and other current assets | -1,266 | 3,472 | -361 |
| (decrease) / increase in accounts payable and accrued liabilities | -546 | -311 | 6,248 |
| Increase in deferred revenue | 2,751 | 614 | 752 |
| Decrease in operating lease liabilities | -3,608 | -3,573 | -14,403 |
| Net cash inflow from operating activities | 6,644 | 15,670 | 45,668 |
| Purchase of property and equipment | 11,732 | 7,639 | 18,375 |
| Cash outflow from sale of subsidiaries, net of cash received | - | - | 0 |
| Net cash outflow from investing activities | -11,732 | -7,639 | -18,375 |
| Proceeds from line of credit | 11,000 | 0 | 82,710 |
| Repayments of line of credit | 11,000 | 0 | 82,710 |
| Repayment of debt | - | - | 0 |
| Proceeds from the exercise of options | 936 | 2,412 | 4,307 |
| Taxes paid related to net share settlement of equity awards | 41 | - | - |
| Principal payments on finance leases | 257 | 292 | 953 |
| Purchase of treasury shares | 2,786 | 2,767 | 78,014 |
| Net cash outflow from financing activities | -2,148 | -647 | -74,660 |
| Effects of exchange rate difference on cash and cash equivalents | 2 | -40 | -3 |
| Net increase / (decrease) in cash and cash equivalents | -7,234 | 7,344 | -47,370 |
| Cash and cash equivalents at beginning of period | 22,694 | 15,350 | - |
| Cash and cash equivalents at end of period | 15,460 | 22,694 | - |
IBEX Ltd (IBEX)
IBEX Ltd (IBEX)